Joe Y Chang (@joechangmd) 's Twitter Profile
Joe Y Chang

@joechangmd

Texas 4000 Distinguished Professor and Director, Stereotactic Ablative Radiotherapy Program, MD Anderson Cancer Center

ID: 3372932260

linkhttp://faculty.mdanderson.org/joe_chang/ calendar_today12-07-2015 20:51:54

406 Tweet

2,2K Takipçi

334 Takip Edilen

Joe Y Chang (@joechangmd) 's Twitter Profile Photo
Joe Y Chang
@joechangmd

2 months ago

First phase III randomized study showed an improvement in overall survival with proton-based IMPT compared to photon IMRT in head and neck cancer. This was presented today during the The Particle Therapy Co-Operative Group (PTCOG) plenary session by Steven J. Frank, MD. The exciting data provides justification for IMPT.

First phase III randomized study showed an improvement in overall survival with proton-based IMPT compared to photon IMRT in head and neck cancer. This was presented today during the <a href="/PTCOG_Official/">The Particle Therapy Co-Operative Group (PTCOG)</a> plenary session by <a href="/SJFrankMD/">Steven J. Frank, MD</a>. The exciting data provides justification for IMPT.